Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-002114

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Jan 25, 2019
Accepted (ET)
Jan 29, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 25, 2019S86,844$14.1417D1,696,859ISee Footnote
Common StockF1,F3Jan 25, 2019S1,693$14.1417D1,695,166ISee Footnote
Common StockF1,F4Jan 25, 2019S595$14.1417D1,694,571ISee Footnote
Common StockF1,F5Jan 25, 2019S868$14.1417D1,693,703ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses